Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Hexamer Therapeutics, Inc

Hexamer Therapeutics, Inc

Stage unknownPullman, WABiotechnology
Facts
Year of incorporation
2019sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
1 rounds
  1. Jan 1, 2024
    Form D equity offering · $651,265 (form d sold) · 9 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Hexamer Therapeutics, Inc filed Form D: $651,265 sold of $6,640,000, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
1 officers, 4 directors
Timeline
1
  1. Jun 27, 2024
    Hexamer Therapeutics, Inc filed Form D: $651,265 sold of $6,640,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
15 observations
Every observation on this company